Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xiyanping Injection for Pediatric Severe Influenza
NCT03947411Unknown
- Sponsor
- Jiangxi Qingfeng Pharmaceutical Co. Ltd.
- Start
- Mar 2019
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of Xiyanping injection + antibiotic in influenza (2 arms), sponsored by Jiangxi Qingfeng Pharmaceutical Co. Ltd. Primary endpoints: Time to Alleviation of Influenza Signs and Symptoms at Day 12 and Duration of Fever at Day 12. Status: unknown.
02
Drugs
Xiyanping injection + antibiotic
03
Conditions
influenza
Beyond the preview
Go deeper on NCT03947411.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03947411.